Scottsdale TMS Therapy has expanded its treatment offerings by introducing FDA-approved Spravato (esketamine) nasal spray for adults with treatment-resistant depression. The addition of this fast-acting therapy addresses a critical gap in care for patients who experience prolonged cycles of pharmaceutical adjustments with conventional antidepressants, which typically take four to six weeks to produce measurable effects.
The clinic, located in Old Town Scottsdale, now provides esketamine therapy alongside existing transcranial magnetic stimulation (TMS) protocols. This integration allows for a comprehensive approach to interventional psychiatry, targeting the biological underpinnings of major depressive disorder at a foundational level. Patients who have not responded to two or more standard antidepressant trials may find a meaningful alternative through this combined treatment strategy.
Spravato operates through a distinct mechanism compared to conventional oral antidepressants. While standard medications modify systemic neurotransmitter levels, esketamine acts directly on NMDA receptors to promote neuroplasticity—the brain's capacity to form new, healthier neural connections and restore circuits involved in emotional regulation. According to a spokesperson for Scottsdale TMS Therapy, "When standard medications fail to deliver remission, it is an indication that the underlying neural networks require a different mechanism of stimulation. Spravato represents a major milestone in complex mood disorder care. Because it can reduce persistent depressive symptoms and decrease suicidal ideation within days rather than weeks, it serves as an immediate lifeline that restores cognitive flexibility and prepares patients for long-term psychological stabilization."
As a tightly regulated medication, esketamine requires structured medical administration. Scottsdale TMS Therapy operates as a fully REMS-certified clinic, satisfying all applicable federal safety and monitoring standards. Each outpatient session includes pre-treatment health screenings, supervised self-administration, and a mandatory two-hour post-treatment observation period during which blood pressure and vital signs are continuously monitored. This structured oversight is provided within a comfort-focused setting designed to minimize patient stress, featuring Apollo TMS chairs, private treatment rooms, an on-site cafe, and an outdoor patio.
To support broad access, the clinic works with major commercial payors and accepts most insurance plans, managing the full authorization process internally. Individuals or family members seeking guidance on interventional options for severe major depressive disorder can contact the clinical admissions team at Scottsdale TMS Therapy for confidential consultations, diagnostic evaluations, and same-day insurance verification to support immediate placement.
